Hh signaling pathway is active in primary CD34+ LSCs and cytokine-responsive CD34+ cell lines (Kasumi-1, Kasumi-3 and TF-1) and contributes to the survival and drug resistance of CD34+ leukemia stem cells [56]. Here, CD34 is linked to leukemia.